Prevalence of high C-reactive protein in persons with serum lipid concentrations within recommended values

Department of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
Clinical Chemistry (Impact Factor: 7.91). 09/2004; 50(9):1618-22. DOI: 10.1373/clinchem.2004.036004
Source: PubMed


C-Reactive protein (CRP) has been shown to be a strong predictor of coronary heart disease (CHD) and is being considered in cardiovascular disease risk assessment. The number of normolipidemic individuals who are eligible for evaluation of CRP in overall CHD risk assessment is not known.
We analyzed data from the National Health and Nutrition Examination Survey 1999-2000 and computed the prevalence of high CRP (>3 mg/L) among normolipidemic adults. We also computed the prevalence among individuals free of CHD and diabetes. In addition, we examined the prevalence stratified by body mass index.
The prevalence of high CRP among those with lipid concentrations within recommended values ranged from 28.8% to 35.3%, depending on the lipid fraction examined. Exclusion of individuals with CHD or diabetes and those with CRP concentrations >10 mg/L reduced the prevalence range (23.1-27.1%). Prevalence increased with increasing body mass index.
In 2000, approximately 12 million adults in the United States considered normolipidemic had high CRP concentrations. Additional studies to explore the role of CRP in cardiovascular disease risk assessment are needed.

Full-text preview

Available from:
  • Source
    • "The 40% prevalence rate of elevated CRP found in our population-based sample of incident Type 2 DM patients in Denmark is similar to levels of elevated CRP found among Hispanics and African-Americans with incident Type 2 DM in the prospective Multi-Ethnic Study of Atherosclerosis (40%) [21]. The prevalence is slightly higher than in previously reported cross-sectional samples of white/European adults from the general population; ranging from 28%-35% [4,5,22] in the adult Spanish population and the general US population included in the 1999-2000 National Health and Nutrition Examination Survey. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background We aimed to examine the prevalence of and modifiable factors associated with elevated C-reactive Protein (CRP), a marker of inflammation, in men and women with newly diagnosed Type 2 Diabetes mellitus (DM) in a population-based setting. Methods CRP was measured in 1,037 patients (57% male) with newly diagnosed Type 2 DM included in the prospective nationwide Danish Centre for Strategic Research in Type 2 Diabetes (DD2) project. We assessed the prevalence of elevated CRP and calculated relative risks (RR) examining the association of CRP with lifestyle and clinical factors by Poisson regression, stratified by gender. We used linear regression to examine the association of CRP with other biomarkers. Results The median CRP value was 2.1 mg/L (interquartile range, 1.0 – 4.8 mg/L). In total, 405 out of the 1,037 Type 2 DM patients (40%) had elevated CRP levels (>3.0 mg/L). More women (46%) than men (34%) had elevated CRP. Among women, a lower risk of elevated CRP was observed in patients receiving statins (adjusted RR (aRR) 0.7 (95% confidence interval (CI) 0.6-0.9)), whereas a higher risk was seen in patients with central obesity (aRR 2.3 (95% CI 1.0-5.3)). For men, CRP was primarily elevated among patients with no regular physical activity (aRR 1.5 (95% CI 1.1-1.9)), previous cardiovascular disease (aRR1.5 (95% CI 1.2-1.9) and other comorbidity. For both genders, elevated CRP was 1.4-fold increased in those with weight gain >30 kg since age 20 years. Sensitivity analyses showed consistent results with the full analysis. The linear regression analysis conveyed an association between high CRP and increased fasting blood glucose. Conclusions Among newly diagnosed Type 2 DM patients, 40% had elevated CRP levels. Important modifiable risk factors for elevated CRP may vary by gender, and include low physical activity for men and central obesity and absence of statin use for women.
    BMC Endocrine Disorders 08/2014; 14(1):74. DOI:10.1186/1472-6823-14-74 · 1.71 Impact Factor
  • Source
    • "Because of the unprecedented growth of Latino populations in many communities across the US and the disproportionate levels of diabetes, metabolic syndrome, and hypertension among older Latinos, these findings point to a great need to examine these associations further in future, larger prospective studies of older Latinos. Levels of biomarkers for this population are higher than that reported in national samples [39]. This could be because this unique sample is sedentary, low SES, and from an urban community [40]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background. Physical activity is associated with better physical health, possibly by changing biological markers of health such as waist circumference and inflammation, but these relationships are unclear and even less understood among older Latinos—a group with high rates of sedentary lifestyle. Methods. Participants were 120 sedentary older Latino adults from senior centers. Community-partnered research methods were used to recruit participants. Inflammatory (C-reactive protein) and metabolic markers of health (waist circumference, HDL-cholesterol, triglycerides, insulin, and glucose), physical activity (Yale physical activity survey), and physical performance (short physical performance NIA battery) were measured at baseline and 6-month follow up. Results. Eighty percent of the sample was female. In final adjusted cross-sectional models, better physical activity indices were associated with faster gait speed (𝑃 < 0.05). In adjusted longitudinal analyses, change in self-reported physical activity level correlated inversely with change in CRP (𝛽 = −0.05; 𝑃 = 0.03) and change in waist circumference (𝛽 = −0.16; 𝑃 = 0.02). Biological markers of health did not mediate the relationship between physical activity and physical performance. Conclusion. In this community-partnered study, higher physical activity was associated with better physical performance in cross-sectional analyses. In longitudinal analysis, increased physical activity was associated with improvements in some metabolic and inflammatory markers of health.
    Current Gerontology and Geriatrics Research 04/2014; 2014(Article ID 535071):8 pages. DOI:10.1155/2014/535071
  • Source
    • "C-reactive protein (CRP) was determined by an automated immunoturbidimetric assay on an Olympus AU600 analyzer (Olympus Optical Co., Tokyo, Japan) (reference value < 5.0 mg/L) [19] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Purpose: The pathogenesis of diabetic retinopathy (DR) is insufficiently understood but may possibly involve chronic, low-grade inflammation. The aim of this cross-sectional study was to investigate the relationship between inflammatory and haemostatic markers, other markers of endothelial dysfunction and anthropometric parameters, and their association with DR in patients with type 2 diabetes. Methods: According to the DR status patients were divided into three groups: no retinopathy, mild/moderate nonproliferative (NPDR), and severe NPDR/proliferative retinopathy (PDR). Results: The groups did not differ in the levels of inflammatory and haemostatic markers, other markers of endothelial dysfunction, and anthropometric parameters. After dividing the patients according to the level of obesity (defined by BMI, WC, and WHR) into three groups ANOVA showed the differences in C-reactive protein according to the WC (P = 0.0265) and in fibrinogen according to the WHR (P = 0.0102) as well as in total cholesterol (P = 0.0109) and triglycerides (P = 0.0133) according to the BMI. Logistic regression analyses showed that diabetes duration and prolonged poor glycemic control are the main predictors of retinopathy in patients with type 2 diabetes. Conclusion: Interrelations between obesity, inflammation, haemostatic disturbance, and other risk factors may possibly play an important additional role in endothelial dysfunction involved in the pathogenesis of diabetic retinopathy.
    Mediators of Inflammation 12/2013; 2013(4):818671. DOI:10.1155/2013/818671 · 3.24 Impact Factor
Show more